NDC codes

401334 NDC codes with hospital pricing data in the network.

• NDC 00409341418 — METOCLOPRAMIDE 5 MG/ML SOLUTION (181 hospitals, 903–3,630 samples)
• NDC 00409318101 — LIDOCAINE-EPINEPHRINE (PF) 1.5 %-1:200,000 INJECTION SOLUTION (104 hospitals, 2,114–3,626 samples)
• NDC 68084060501 — FLUoxetine 20 mg cap (69 hospitals, 3,552–3,624 samples)
• NDC 66993073080 — DEXAMETHASONE 4 MG PO TABS (80 hospitals, 2,918–3,620 samples)
• NDC 23155029442 — 23155-0294-42 - prochlorperazine 5 mg/mL Soln (318 hospitals, 1,098–3,618 samples)
• NDC 60505-6152-01 — CEFTRIAXONE SODIUM 500 MG IJ SOLR (63 hospitals, 2,978–3,617 samples)
• NDC 00641606101 — MIDAZOLAM 5 MG/ML INJECTION SOLUTION (102 hospitals, 1,631–3,611 samples)
• NDC 00409672903 — 24 POUCH in 1 CASE (0409-6729-03) / 1 BAG in 1 POUCH / 500 mL in 1 BAG (0409-6729-21) (150 hospitals, 1,541–3,611 samples)
• NDC 00990-7075-26 — POTASSIUM CHLORIDE IN WATER 20 MEQ/100 ML IV PGBK (116 hospitals, 3,511–3,610 samples)
• NDC 00641-0376-21 — DIPHENHYDRAMINE HCL 50 MG/ML INJ SOLN (150 hospitals, 2,439–3,609 samples)
• NDC 60687029501 — propranolol 40 mg Tab (37 hospitals, 3,550–3,604 samples)
• NDC 63402030810 — 63402-0308-10 - lurasidone 80 mg Tab (39 hospitals, 3,550–3,604 samples)
• NDC 68084059101 — ISOSORBIDE MONONITRATE 30 MG ORAL TB24 (98 hospitals, 3,550–3,604 samples)
• NDC 68084074825 — Guanfacine Hydrochloride: 30 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-748-25) / 1 TABLET in 1 BLISTER PACK (68084-748-95) (62 hospitals, 3,550–3,604 samples)
• NDC 68180072204 — CEFDINIR 125 MG/5ML PO SUSR (52 hospitals, 3,550–3,604 samples)
• NDC 69097086283 — CALCIUM ACETATE (PHOSPHATE BINDER) CAP 667 MG (169 MG CA) (57 hospitals, 3,550–3,604 samples)
• NDC 76385010301 — benztropine 0.5 mg Tab [CITY] (41 hospitals, 3,550–3,604 samples)
• NDC 50383007916 — ACETAMINOPHEN 120 MG-CODEINE 12 MG/5 ML ORAL SOLUTION (79 hospitals, 3,550–3,604 samples)
• NDC 60505367303 — 60505-3673-03 - paroxetine 12.5 mg Tab-ER (37 hospitals, 3,550–3,604 samples)
• NDC 63739057110 — Simvastatin (68 hospitals, 3,550–3,604 samples)
• NDC 29033002602 — calcium acetate 667 mg Cap (76 hospitals, 3,550–3,604 samples)
• NDC 66993042285 — 66993-0422-85 - lanthanum carbonate 500 mg Tab-Ch (111 hospitals, 3,550–3,604 samples)
• NDC 23155053102 — CALCIUM ACETATE(PHOSPHATE BINDERS) 667 MG CAPSULE (100 hospitals, 3,550–3,604 samples)
• NDC 50268039950 — HYDROXYZINE PAMOATE 50 MG CAPSULE (45 hospitals, 3,550–3,604 samples)
• NDC 60687040101 — LORazepam 0.5 MG tablet 100 each Box (28 hospitals, 3,550–3,604 samples)
• NDC 00409909337 — FENTANYL (PF) 50 MCG/ML INJECTION SOLUTION (78 hospitals, 2,244–3,603 samples)
• NDC 63323-0738-20 — FAMOTIDINE 200 MG/20ML IV SOLN (58 hospitals, 3,567–3,603 samples)
• NDC 00409909345 — FENTANYL (PF) 50 MCG/ML INJECTION SOLUTION (67 hospitals, 2,244–3,603 samples)
• NDC 00407270703 — PERFLUTREN PROTEIN-TYPE A MICROSPHERES 0.22 MG/ML INTRAVENOUS SUSP [82177] (176 hospitals, 1,371–3,603 samples)
• NDC 70092140043 — FENTANYL CITRATE-NACL 10-0.9 MCG/ML-% IV SOSY (125 hospitals, 2,244–3,603 samples)
• NDC 00409127603 — FENTANYL (PF) 100 MCG/2 ML (50 MCG/ML) INTRAVENOUS SYRINGE (25 hospitals, 2,244–3,603 samples)
• NDC 63323081000 — Fentanyl Citrate Inj 0.05 MG/ML,Fentanyl Citrate Preservative Free (PF) Inj 100 MCG/2ML,Fentanyl Citrate Preservative Free (PF) Inj 1000 MCG/20ML,Fentanyl Citrate Preservative Free (PF) Inj 250 MCG/5ML,Fentanyl Citrate Preservative Free (PF) Inj 2500 MCG/50ML,Fentanyl Citrate Preservative Free (PF) Inj 500 MCG/10ML,Fentanyl Citrate PF Soln Cartridge 100 MCG/2ML,Fentanyl Citrate (PF) IV Soln Prefilled Syringe 100 MCG/2ML,Fentanyl Citrate Soln Prefilled Syringe 50 MCG/ML,Fentanyl Citrate Soln Prefilled Syringe 100 MCG/2ML,Fentanyl Citrate Preservative Free (PF) Inj 50 MCG/ML,Fentanyl Citrate IV Soln 2500 MCG/50ML,Fentanyl Citrate PF Soln Prefilled Syringe 50 MCG/ML (29 hospitals, 2,244–3,603 samples)
• NDC 70004022209 — FENTANYL (PF) 250 MCG/5 ML (50 MCG/ML) INTRAVENOUS SYRINGE (24 hospitals, 2,244–3,603 samples)
• NDC 71266918001 — FENTANYL (PF) 10 MCG/ML IN 0.9 % SODIUM CHLORIDE INTRAVENOUS SYRINGE (55 hospitals, 2,244–3,603 samples)
• NDC 61141131801 — FENTANYL (PF) 10 MCG/ML IN 0.9 % SODIUM CHLORIDE INTRAVENOUS (27 hospitals, 2,244–3,603 samples)
• NDC 09990515600 — FENTANYL (PF) 10 MCG/ML IN 0.9 % SODIUM CHLORIDE INTRAVENOUS (23 hospitals, 2,244–3,603 samples)
• NDC 44567042424 — MAGNESIUM SULFATE 4 GM/50ML IV SOLN (146 hospitals, 1,573–3,598 samples)
• NDC 25021010110 — CEFAZOLIN 1 GRAM SOLUTION FOR INJECTION (182 hospitals, 1,095–3,597 samples)
• NDC 69374-0302-10 — PHENYLEPH 0.1MG/ML10ML NS (37 hospitals, 3,345–3,588 samples)
• NDC 63323010802 — MAGNESIUM SULFATE 1 GRAM/100 ML IN DEXTROSE 5 % INTRAVENOUS PIGGYBACK (60 hospitals, 1,572–3,588 samples)
• NDC 00002821517 — INSULIN SUBCUTANEOUS BASAL PUMP - HUMAN (HUMULIN R) (199 hospitals, 1,526–3,587 samples)
• NDC 00338519741 — famotidine 0.4 mg/mL Soln 50 mL Bag (131 hospitals, 985–3,586 samples)
• NDC 00264762200 — IV D10W / 0.9% NACL 1000 ML (80 hospitals, 2,263–3,586 samples)
• NDC 00409317818 — LIDOCAINE 1 %-EPINEPHRINE 1:100,000 INJECTION SOLUTION (112 hospitals, 2,110–3,586 samples)
• NDC 00641612501 — MORPHINE SULFATE IV SOLN 4 MG/ML (220 hospitals, 733–3,586 samples)
• NDC 23155060142 — MIDAZOLAM 5 MG/ML INJECTION SOLUTION (118 hospitals, 1,718–3,581 samples)
• NDC 00409205020 — Magnesium Sulfate (111 hospitals, 1,670–3,578 samples)
• NDC 70954-0258-10 — SULFAMETHOXAZOLE-TRIMETHOPRIM 200-40 MG/5ML PO SUSP (70 hospitals, 3,459–3,576 samples)
• NDC 00409317817 — lidocaine HCl-EPINEPHrine (95 hospitals, 2,109–3,576 samples)
• NDC 58160091241 — FLU VACCINE TS 2025-26(6MOS UP)(PF) 45 MCG(15MCG X3)/0.5 ML IM SYRINGE (98 hospitals, 3,464–3,572 samples)